Infection Prevention and Enteral Access Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Infection Prevention and Enteral Access Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infection Prevention and Enteral Access Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infection Prevention and Enteral Access Overall Market Size
2.1 Global Infection Prevention and Enteral Access Market Size: 2021 VS 2027
2.2 Global Infection Prevention and Enteral Access Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Infection Prevention and Enteral Access Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Infection Prevention and Enteral Access Players in Global Market
3.2 Top Global Infection Prevention and Enteral Access Companies Ranked by Revenue
3.3 Global Infection Prevention and Enteral Access Revenue by Companies
3.4 Global Infection Prevention and Enteral Access Sales by Companies
3.5 Global Infection Prevention and Enteral Access Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Infection Prevention and Enteral Access Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Infection Prevention and Enteral Access Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infection Prevention and Enteral Access Players in Global Market
3.8.1 List of Global Tier 1 Infection Prevention and Enteral Access Companies
3.8.2 List of Global Tier 2 and Tier 3 Infection Prevention and Enteral Access Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Infection Prevention and Enteral Access Market Size Markets, 2021 & 2027
4.1.2 Enteral Feeding Pumps
4.1.3 Enteral Feeding Tubes
4.1.4 Administration Reservoirs
4.1.5 Giving Sets
4.1.6 Enteral Syringes
4.2 By Type - Global Infection Prevention and Enteral Access Revenue & Forecasts
4.2.1 By Type - Global Infection Prevention and Enteral Access Revenue, 2016-2021
4.2.2 By Type - Global Infection Prevention and Enteral Access Revenue, 2022-2027
4.2.3 By Type - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
4.3 By Type - Global Infection Prevention and Enteral Access Sales & Forecasts
4.3.1 By Type - Global Infection Prevention and Enteral Access Sales, 2016-2021
4.3.2 By Type - Global Infection Prevention and Enteral Access Sales, 2022-2027
4.3.3 By Type - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
4.4 By Type - Global Infection Prevention and Enteral Access Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infection Prevention and Enteral Access Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Gastroenterology
5.1.4 Diabetes
5.1.5 Neurological Disorders
5.1.6 Hypermetabolism
5.1.7 Others
5.2 By Application - Global Infection Prevention and Enteral Access Revenue & Forecasts
5.2.1 By Application - Global Infection Prevention and Enteral Access Revenue, 2016-2021
5.2.2 By Application - Global Infection Prevention and Enteral Access Revenue, 2022-2027
5.2.3 By Application - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
5.3 By Application - Global Infection Prevention and Enteral Access Sales & Forecasts
5.3.1 By Application - Global Infection Prevention and Enteral Access Sales, 2016-2021
5.3.2 By Application - Global Infection Prevention and Enteral Access Sales, 2022-2027
5.3.3 By Application - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
5.4 By Application - Global Infection Prevention and Enteral Access Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Infection Prevention and Enteral Access Market Size, 2021 & 2027
6.2 By Region - Global Infection Prevention and Enteral Access Revenue & Forecasts
6.2.1 By Region - Global Infection Prevention and Enteral Access Revenue, 2016-2021
6.2.2 By Region - Global Infection Prevention and Enteral Access Revenue, 2022-2027
6.2.3 By Region - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
6.3 By Region - Global Infection Prevention and Enteral Access Sales & Forecasts
6.3.1 By Region - Global Infection Prevention and Enteral Access Sales, 2016-2021
6.3.2 By Region - Global Infection Prevention and Enteral Access Sales, 2022-2027
6.3.3 By Region - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Infection Prevention and Enteral Access Revenue, 2016-2027
6.4.2 By Country - North America Infection Prevention and Enteral Access Sales, 2016-2027
6.4.3 US Infection Prevention and Enteral Access Market Size, 2016-2027
6.4.4 Canada Infection Prevention and Enteral Access Market Size, 2016-2027
6.4.5 Mexico Infection Prevention and Enteral Access Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Infection Prevention and Enteral Access Revenue, 2016-2027
6.5.2 By Country - Europe Infection Prevention and Enteral Access Sales, 2016-2027
6.5.3 Germany Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.4 France Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.5 U.K. Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.6 Italy Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.7 Russia Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.8 Nordic Countries Infection Prevention and Enteral Access Market Size, 2016-2027
6.5.9 Benelux Infection Prevention and Enteral Access Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Infection Prevention and Enteral Access Revenue, 2016-2027
6.6.2 By Region - Asia Infection Prevention and Enteral Access Sales, 2016-2027
6.6.3 China Infection Prevention and Enteral Access Market Size, 2016-2027
6.6.4 Japan Infection Prevention and Enteral Access Market Size, 2016-2027
6.6.5 South Korea Infection Prevention and Enteral Access Market Size, 2016-2027
6.6.6 Southeast Asia Infection Prevention and Enteral Access Market Size, 2016-2027
6.6.7 India Infection Prevention and Enteral Access Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Infection Prevention and Enteral Access Revenue, 2016-2027
6.7.2 By Country - South America Infection Prevention and Enteral Access Sales, 2016-2027
6.7.3 Brazil Infection Prevention and Enteral Access Market Size, 2016-2027
6.7.4 Argentina Infection Prevention and Enteral Access Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infection Prevention and Enteral Access Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Infection Prevention and Enteral Access Sales, 2016-2027
6.8.3 Turkey Infection Prevention and Enteral Access Market Size, 2016-2027
6.8.4 Israel Infection Prevention and Enteral Access Market Size, 2016-2027
6.8.5 Saudi Arabia Infection Prevention and Enteral Access Market Size, 2016-2027
6.8.6 UAE Infection Prevention and Enteral Access Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Cook Medical
7.1.1 Cook Medical Corporate Summary
7.1.2 Cook Medical Business Overview
7.1.3 Cook Medical Infection Prevention and Enteral Access Major Product Offerings
7.1.4 Cook Medical Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.1.5 Cook Medical Key News
7.2 Medtronic Plc
7.2.1 Medtronic Plc Corporate Summary
7.2.2 Medtronic Plc Business Overview
7.2.3 Medtronic Plc Infection Prevention and Enteral Access Major Product Offerings
7.2.4 Medtronic Plc Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.2.5 Medtronic Plc Key News
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Corporate Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Major Product Offerings
7.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.3.5 Boston Scientific Corporation Key News
7.4 CONMED Corporation
7.4.1 CONMED Corporation Corporate Summary
7.4.2 CONMED Corporation Business Overview
7.4.3 CONMED Corporation Infection Prevention and Enteral Access Major Product Offerings
7.4.4 CONMED Corporation Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.4.5 CONMED Corporation Key News
7.5 CORPAK MedSystems
7.5.1 CORPAK MedSystems Corporate Summary
7.5.2 CORPAK MedSystems Business Overview
7.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Major Product Offerings
7.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.5.5 CORPAK MedSystems Key News
7.6 CR Bard
7.6.1 CR Bard Corporate Summary
7.6.2 CR Bard Business Overview
7.6.3 CR Bard Infection Prevention and Enteral Access Major Product Offerings
7.6.4 CR Bard Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.6.5 CR Bard Key News
7.7 ALCOR Scientific
7.7.1 ALCOR Scientific Corporate Summary
7.7.2 ALCOR Scientific Business Overview
7.7.3 ALCOR Scientific Infection Prevention and Enteral Access Major Product Offerings
7.4.4 ALCOR Scientific Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.7.5 ALCOR Scientific Key News
7.8 Pacific Hospital Supply
7.8.1 Pacific Hospital Supply Corporate Summary
7.8.2 Pacific Hospital Supply Business Overview
7.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Major Product Offerings
7.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.8.5 Pacific Hospital Supply Key News
7.9 Teleflexorporated
7.9.1 Teleflexorporated Corporate Summary
7.9.2 Teleflexorporated Business Overview
7.9.3 Teleflexorporated Infection Prevention and Enteral Access Major Product Offerings
7.9.4 Teleflexorporated Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.9.5 Teleflexorporated Key News
7.10 Vygon SA
7.10.1 Vygon SA Corporate Summary
7.10.2 Vygon SA Business Overview
7.10.3 Vygon SA Infection Prevention and Enteral Access Major Product Offerings
7.10.4 Vygon SA Infection Prevention and Enteral Access Sales and Revenue in Global (2016-2021)
7.10.5 Vygon SA Key News
8 Global Infection Prevention and Enteral Access Production Capacity, Analysis
8.1 Global Infection Prevention and Enteral Access Production Capacity, 2016-2027
8.2 Infection Prevention and Enteral Access Production Capacity of Key Manufacturers in Global Market
8.3 Global Infection Prevention and Enteral Access Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Infection Prevention and Enteral Access Supply Chain Analysis
10.1 Infection Prevention and Enteral Access Industry Value Chain
10.2 Infection Prevention and Enteral Access Upstream Market
10.3 Infection Prevention and Enteral Access Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infection Prevention and Enteral Access Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Infection Prevention and Enteral Access in Global Market
Table 2. Top Infection Prevention and Enteral Access Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Infection Prevention and Enteral Access Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Infection Prevention and Enteral Access Revenue Share by Companies, 2016-2021
Table 5. Global Infection Prevention and Enteral Access Sales by Companies, (K Units), 2016-2021
Table 6. Global Infection Prevention and Enteral Access Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Infection Prevention and Enteral Access Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Infection Prevention and Enteral Access Product Type
Table 9. List of Global Tier 1 Infection Prevention and Enteral Access Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infection Prevention and Enteral Access Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Infection Prevention and Enteral Access Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Infection Prevention and Enteral Access Sales (K Units), 2016-2021
Table 15. By Type - Global Infection Prevention and Enteral Access Sales (K Units), 2022-2027
Table 16. By Application - Global Infection Prevention and Enteral Access Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Infection Prevention and Enteral Access Sales (K Units), 2016-2021
Table 20. By Application - Global Infection Prevention and Enteral Access Sales (K Units), 2022-2027
Table 21. By Region - Global Infection Prevention and Enteral Access Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Infection Prevention and Enteral Access Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Infection Prevention and Enteral Access Sales (K Units), 2016-2021
Table 25. By Region - Global Infection Prevention and Enteral Access Sales (K Units), 2022-2027
Table 26. By Country - North America Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Infection Prevention and Enteral Access Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Infection Prevention and Enteral Access Sales, (K Units), 2016-2021
Table 29. By Country - North America Infection Prevention and Enteral Access Sales, (K Units), 2022-2027
Table 30. By Country - Europe Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Infection Prevention and Enteral Access Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Infection Prevention and Enteral Access Sales, (K Units), 2016-2021
Table 33. By Country - Europe Infection Prevention and Enteral Access Sales, (K Units), 2022-2027
Table 34. By Region - Asia Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Infection Prevention and Enteral Access Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Infection Prevention and Enteral Access Sales, (K Units), 2016-2021
Table 37. By Region - Asia Infection Prevention and Enteral Access Sales, (K Units), 2022-2027
Table 38. By Country - South America Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Infection Prevention and Enteral Access Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Infection Prevention and Enteral Access Sales, (K Units), 2016-2021
Table 41. By Country - South America Infection Prevention and Enteral Access Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Infection Prevention and Enteral Access Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Infection Prevention and Enteral Access Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Infection Prevention and Enteral Access Sales, (K Units), 2022-2027
Table 46. Cook Medical Corporate Summary
Table 47. Cook Medical Infection Prevention and Enteral Access Product Offerings
Table 48. Cook Medical Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Medtronic Plc Corporate Summary
Table 50. Medtronic Plc Infection Prevention and Enteral Access Product Offerings
Table 51. Medtronic Plc Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Boston Scientific Corporation Corporate Summary
Table 53. Boston Scientific Corporation Infection Prevention and Enteral Access Product Offerings
Table 54. Boston Scientific Corporation Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. CONMED Corporation Corporate Summary
Table 56. CONMED Corporation Infection Prevention and Enteral Access Product Offerings
Table 57. CONMED Corporation Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. CORPAK MedSystems Corporate Summary
Table 59. CORPAK MedSystems Infection Prevention and Enteral Access Product Offerings
Table 60. CORPAK MedSystems Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. CR Bard Corporate Summary
Table 62. CR Bard Infection Prevention and Enteral Access Product Offerings
Table 63. CR Bard Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. ALCOR Scientific Corporate Summary
Table 65. ALCOR Scientific Infection Prevention and Enteral Access Product Offerings
Table 66. ALCOR Scientific Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Pacific Hospital Supply Corporate Summary
Table 68. Pacific Hospital Supply Infection Prevention and Enteral Access Product Offerings
Table 69. Pacific Hospital Supply Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Teleflexorporated Corporate Summary
Table 71. Teleflexorporated Infection Prevention and Enteral Access Product Offerings
Table 72. Teleflexorporated Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Vygon SA Corporate Summary
Table 74. Vygon SA Infection Prevention and Enteral Access Product Offerings
Table 75. Vygon SA Infection Prevention and Enteral Access Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Infection Prevention and Enteral Access Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 77. Global Infection Prevention and Enteral Access Capacity Market Share of Key Manufacturers, 2019-2021
Table 78. Global Infection Prevention and Enteral Access Production by Region, 2016-2021 (K Units)
Table 79. Global Infection Prevention and Enteral Access Production by Region, 2022-2027 (K Units)
Table 80. Infection Prevention and Enteral Access Market Opportunities & Trends in Global Market
Table 81. Infection Prevention and Enteral Access Market Drivers in Global Market
Table 82. Infection Prevention and Enteral Access Market Restraints in Global Market
Table 83. Infection Prevention and Enteral Access Raw Materials
Table 84. Infection Prevention and Enteral Access Raw Materials Suppliers in Global Market
Table 85. Typical Infection Prevention and Enteral Access Downstream
Table 86. Infection Prevention and Enteral Access Downstream Clients in Global Market
Table 87. Infection Prevention and Enteral Access Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Infection Prevention and Enteral Access Segment by Type
Figure 2. Infection Prevention and Enteral Access Segment by Application
Figure 3. Global Infection Prevention and Enteral Access Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Infection Prevention and Enteral Access Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Infection Prevention and Enteral Access Revenue, 2016-2027 (US$, Mn)
Figure 7. Infection Prevention and Enteral Access Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infection Prevention and Enteral Access Revenue in 2020
Figure 9. By Type - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 10. By Type - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 11. By Type - Global Infection Prevention and Enteral Access Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 13. By Application - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 14. By Application - Global Infection Prevention and Enteral Access Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 16. By Region - Global Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 17. By Country - North America Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 18. By Country - North America Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 19. US Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 24. Germany Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 25. France Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 33. China Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 37. India Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 39. By Country - South America Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 40. Brazil Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Infection Prevention and Enteral Access Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Infection Prevention and Enteral Access Sales Market Share, 2016-2027
Figure 44. Turkey Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Infection Prevention and Enteral Access Revenue, (US$, Mn), 2016-2027
Figure 48. Global Infection Prevention and Enteral Access Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Infection Prevention and Enteral Access by Region, 2020 VS 2027
Figure 50. Infection Prevention and Enteral Access Industry Value Chain
Figure 51. Marketing Channels

Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA